Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3

Abstract Most cancer‐related deaths are a result of metastasis. The development of small molecular inhibitors reversing cancer metastasis represents a promising therapeutic opportunity for cancer patients. This pan‐cancer analysis identifies oncogenic roles of membrane‐associated phosphatidylinosito...

Full description

Bibliographic Details
Main Authors: Zihao Liu, Yu Shi, Li Lv, Jianing Chen, WenG. Jiang, Jun Li, Qun Lin, Xiaolin Fang, Jingbo Gao, Yujie Liu, Qiang Liu, Xiaoding Xu, Erwei Song, Chang Gong
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202204649
_version_ 1798004377513885696
author Zihao Liu
Yu Shi
Li Lv
Jianing Chen
WenG. Jiang
Jun Li
Qun Lin
Xiaolin Fang
Jingbo Gao
Yujie Liu
Qiang Liu
Xiaoding Xu
Erwei Song
Chang Gong
author_facet Zihao Liu
Yu Shi
Li Lv
Jianing Chen
WenG. Jiang
Jun Li
Qun Lin
Xiaolin Fang
Jingbo Gao
Yujie Liu
Qiang Liu
Xiaoding Xu
Erwei Song
Chang Gong
author_sort Zihao Liu
collection DOAJ
description Abstract Most cancer‐related deaths are a result of metastasis. The development of small molecular inhibitors reversing cancer metastasis represents a promising therapeutic opportunity for cancer patients. This pan‐cancer analysis identifies oncogenic roles of membrane‐associated phosphatidylinositol transfer protein 3 (PITPNM3), which is crucial for cancer metastasis. Small molecules targeting PITPNM3 must be explored further. Here, PITPNM3‐selective small molecular inhibitors are reported. These compounds exhibit target‐specific inhibition of PITPNM3 signaling, thereby reducing metastasis of breast cancer cells. Besides, by using nanoparticle‐based delivery systems, these PITPNM3‐selective compounds loaded nanoparticles significantly repress metastasis of breast cancer in mouse xenograft models and organoid models. Notably, the results establish an important metastatic‐promoting role for PITPNM3 and offer PITPNM3 inhibition as a therapeutic strategy in metastatic breast cancer.
first_indexed 2024-04-11T12:23:52Z
format Article
id doaj.art-993f5465e7054b208db2e1bacbf17da8
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-04-11T12:23:52Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-993f5465e7054b208db2e1bacbf17da82022-12-22T04:24:02ZengWileyAdvanced Science2198-38442022-12-01935n/an/a10.1002/advs.202204649Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3Zihao Liu0Yu Shi1Li Lv2Jianing Chen3WenG. Jiang4Jun Li5Qun Lin6Xiaolin Fang7Jingbo Gao8Yujie Liu9Qiang Liu10Xiaoding Xu11Erwei Song12Chang Gong13Breast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaCardiff China Medical Research Collaborative School of Medicine Cardiff University Heath Park Cardiff CF14 4XN UKDepartment of Biochemistry Zhongshan School of Medicine Sun Yat‐sen University Guangzhou 510080 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaBreast Tumor Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 P. R. ChinaAbstract Most cancer‐related deaths are a result of metastasis. The development of small molecular inhibitors reversing cancer metastasis represents a promising therapeutic opportunity for cancer patients. This pan‐cancer analysis identifies oncogenic roles of membrane‐associated phosphatidylinositol transfer protein 3 (PITPNM3), which is crucial for cancer metastasis. Small molecules targeting PITPNM3 must be explored further. Here, PITPNM3‐selective small molecular inhibitors are reported. These compounds exhibit target‐specific inhibition of PITPNM3 signaling, thereby reducing metastasis of breast cancer cells. Besides, by using nanoparticle‐based delivery systems, these PITPNM3‐selective compounds loaded nanoparticles significantly repress metastasis of breast cancer in mouse xenograft models and organoid models. Notably, the results establish an important metastatic‐promoting role for PITPNM3 and offer PITPNM3 inhibition as a therapeutic strategy in metastatic breast cancer.https://doi.org/10.1002/advs.202204649metastasispan‐cancer analysisPITPNM3small molecular inhibitors
spellingShingle Zihao Liu
Yu Shi
Li Lv
Jianing Chen
WenG. Jiang
Jun Li
Qun Lin
Xiaolin Fang
Jingbo Gao
Yujie Liu
Qiang Liu
Xiaoding Xu
Erwei Song
Chang Gong
Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
Advanced Science
metastasis
pan‐cancer analysis
PITPNM3
small molecular inhibitors
title Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
title_full Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
title_fullStr Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
title_full_unstemmed Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
title_short Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
title_sort small molecular inhibitors reverse cancer metastasis by blockading oncogenic pitpnm3
topic metastasis
pan‐cancer analysis
PITPNM3
small molecular inhibitors
url https://doi.org/10.1002/advs.202204649
work_keys_str_mv AT zihaoliu smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT yushi smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT lilv smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT jianingchen smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT wengjiang smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT junli smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT qunlin smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT xiaolinfang smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT jingbogao smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT yujieliu smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT qiangliu smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT xiaodingxu smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT erweisong smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3
AT changgong smallmolecularinhibitorsreversecancermetastasisbyblockadingoncogenicpitpnm3